Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Katayama

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Hematology|July 29, 2023
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research CommitteeShin-Ichi Fuchida, Mizuki Ogura, Tadao Ishida, et al.
Transplantation and Cellular Therapy|February 8, 2024
Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity ConditioningShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Journal of Blood Medicine|February 6, 2016
Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Yoshinobu Maeda, Kazuyoshi Ishii, et al.
Transplantation and Cellular Therapy|January 14, 2023
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor TypesKatsuji Kaida, Kazuhiro Ikegame, Takayuki Inoue, et al.
International Journal of Hematology|March 12, 2025
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE studyTatsunori Goto, Hiroshi Okamura, Takashi Ikeda, et al.
Annals of Hematology|September 17, 2020
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCTSatoshi Yamasaki, Jinichi Mori, Junya Kanda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2017
Decreased Brain pH as a Shared Endophenotype of Psychiatric DisordersHideo Hagihara, Vibeke S Catts, Yuta Katayama, et al.
Annals of Hematology|October 9, 2020
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemiaYasushi Onishi, Takehiko Mori, Hirohito Yamazaki, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Blood Cell Therapy|July 19, 2023
Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantationMinako Iida, Hideki Nakasone, Takuya Yamashita, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Hematology|July 29, 2023
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research CommitteeShin-Ichi Fuchida, Mizuki Ogura, Tadao Ishida, et al.
Transplantation and Cellular Therapy|February 8, 2024
Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity ConditioningShuhei Kurosawa, Yoshimitsu Shimomura, Hidehiro Itonaga, et al.
Journal of Blood Medicine|February 6, 2016
Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Yoshinobu Maeda, Kazuyoshi Ishii, et al.
Transplantation and Cellular Therapy|January 14, 2023
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor TypesKatsuji Kaida, Kazuhiro Ikegame, Takayuki Inoue, et al.
International Journal of Hematology|March 12, 2025
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE studyTatsunori Goto, Hiroshi Okamura, Takashi Ikeda, et al.
Annals of Hematology|September 17, 2020
Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCTSatoshi Yamasaki, Jinichi Mori, Junya Kanda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2017
Decreased Brain pH as a Shared Endophenotype of Psychiatric DisordersHideo Hagihara, Vibeke S Catts, Yuta Katayama, et al.
Annals of Hematology|October 9, 2020
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemiaYasushi Onishi, Takehiko Mori, Hirohito Yamazaki, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Blood Cell Therapy|July 19, 2023
Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantationMinako Iida, Hideki Nakasone, Takuya Yamashita, et al.
Pageof 16